Data / Drug companies / Metrochem Api Private Limited
Metrochem Api Private Limited: 81 products in the FDA NDC directory, labeler code 42765
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Metrochem Api Private Limited (labeler code 42765) lists 81 products in the FDA National Drug Code Directory. By type: 81 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on February 1, 2025.
The request: Watch Metrochem Api Private Limited (FDA labeler code 42765): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 42765
- Products in commercial distribution
- 81
- Packages
- 97
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule V 2
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- January 23, 2018
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 81 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 81 | 100% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 81 | 100% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Saxagliptin hydrochloride dihydrate | 42765-076 | Powder | Bulk ingredients | February 1, 2025 |
| Vortioxetine hydrobromide | 42765-070 | Powder | Bulk ingredients | December 31, 2024 |
| Vortioxetine hydrochloride | 42765-069 | Powder | Bulk ingredients | December 31, 2024 |
| Cenobamate | 42765-071 | Powder | Bulk ingredients | October 28, 2024 |
| Uridine triacetate | 42765-074 | Powder | Bulk ingredients | August 13, 2024 |
| Upadacitinib hemihydrate | 42765-073 | Powder | Bulk ingredients | July 30, 2024 |
| Isavuconazonium sulfate (kyo) | 42765-068 | Powder | Bulk ingredients | April 30, 2024 |
| Trelagliptin succinate | 42765-072 | Powder | Bulk ingredients | March 31, 2024 |
| Eltrombopag olamine | 42765-067 | Powder | Bulk ingredients | January 1, 2024 |
| Dexlansoprazole | 42765-066 | Powder | Bulk ingredients | November 20, 2023 |
| Teneligliptin hydrochloride hydrate | 42765-064 | Powder | Bulk ingredients | October 1, 2023 |
| Tegoprazan | 42765-065 | Powder | Bulk ingredients | August 1, 2023 |
| Edoxaban tosylate monohydrate | 42765-063 | Powder | Bulk ingredients | July 1, 2023 |
| Dexlansoprazole | 42765-062 | Powder | Bulk ingredients | July 1, 2023 |
| Lacosamide | 42765-060 | Powder | Bulk ingredients | June 28, 2023 |
| Vigabatrin | 42765-059 | Powder | Bulk ingredients | June 14, 2023 |
| Stiripentol | 42765-058 | Powder | Bulk ingredients | March 15, 2023 |
| Alogliptin benzoate | 42765-057 | Powder | Bulk ingredients | January 24, 2023 |
| Edoxaban tosylate monohydrate | 42765-056 | Powder | Bulk ingredients | January 24, 2023 |
| Fosravuconazole l-lysine ethanolate | 42765-055 | Powder | Bulk ingredients | January 24, 2023 |
| Dabigatran etexilate mesylate | 42765-054 | Powder | Bulk ingredients | January 24, 2023 |
| Rabeprazole sodium (y-form) | 42765-053 | Powder | Bulk ingredients | January 24, 2023 |
| Elobixibat hydrate | 42765-052 | Powder | Bulk ingredients | January 24, 2023 |
| Migalastat hydrochloride | 42765-051 | Powder | Bulk ingredients | January 24, 2023 |
| Tofacitinib citrate | 42765-061 | Powder | Bulk ingredients | January 1, 2023 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.